Reminder: Information to holders of warrants of series TO 5 and TO 6 in Subgen AI AB ahead of the upcoming exercise period for TO 5
Idag, 11:15
Idag, 11:15
The subscription period for warrants of series TO 5 ("TO 5") in Subgen AI AB ("Subgen AI" or the "Company") runs from 18 May 2026 up to and including 1 June 2026. Ahead of the exercise period, Subgen AI wishes to draw warrant holders' attention to the recalculated terms for TO 5, as well as for warrants of series TO 6 ("TO 6"), following the reverse share split (1:1,000) with record date 26 November 2025 and as previously announced in the Company's press release dated 20 November 2025. In relation to the upcoming exercise of TO 5, warrant holders are encouraged to consider that the prevailing market price of the ordinary share is significantly lower than the subscription price when evaluating whether to exercise their warrants. Warrants of series TO 5 that are not exercised during the exercise period, or sold before the last day of trading, will expire and become void without any compensation to the holder.
Recalculated terms for warrants of series TO 5
Recalculated terms for warrants of series TO 6
For further information, please contact:
Lorenzo Serratosa, CEO Subgen AI AB
Email: ir@subgen.ai
About Subgen AI
Subgen AI (Nasdaq First North: SUBGEN) is a Stockholm-headquartered enterprise AI company serving clients in healthcare, financial services, energy, and the public sector across Europe, the United States, and Latin America. Its flagship platform, Serenity Star, enables organisations to deploy, govern, and scale generative AI with full EU AI Act compliance and data sovereignty. For more information, visit https://subgen.ai.
The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.se
Idag, 11:15
The subscription period for warrants of series TO 5 ("TO 5") in Subgen AI AB ("Subgen AI" or the "Company") runs from 18 May 2026 up to and including 1 June 2026. Ahead of the exercise period, Subgen AI wishes to draw warrant holders' attention to the recalculated terms for TO 5, as well as for warrants of series TO 6 ("TO 6"), following the reverse share split (1:1,000) with record date 26 November 2025 and as previously announced in the Company's press release dated 20 November 2025. In relation to the upcoming exercise of TO 5, warrant holders are encouraged to consider that the prevailing market price of the ordinary share is significantly lower than the subscription price when evaluating whether to exercise their warrants. Warrants of series TO 5 that are not exercised during the exercise period, or sold before the last day of trading, will expire and become void without any compensation to the holder.
Recalculated terms for warrants of series TO 5
Recalculated terms for warrants of series TO 6
For further information, please contact:
Lorenzo Serratosa, CEO Subgen AI AB
Email: ir@subgen.ai
About Subgen AI
Subgen AI (Nasdaq First North: SUBGEN) is a Stockholm-headquartered enterprise AI company serving clients in healthcare, financial services, energy, and the public sector across Europe, the United States, and Latin America. Its flagship platform, Serenity Star, enables organisations to deploy, govern, and scale generative AI with full EU AI Act compliance and data sovereignty. For more information, visit https://subgen.ai.
The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.se
Analys
Trump besöker Kina
Regeringens krispaket
Analys
Trump besöker Kina
Regeringens krispaket
1 DAG %
Senast
OMX Stockholm 30
−0,11%
(13:11)
OMX Stockholm 30
1 DAG %
Senast
3 044,94